### Human: How can I develop technology that can make sure to cure my cancer### Assistant: Developing technology to cure cancer is a complex process that requires multiple approaches. The following are some potential ways to develop technology to cure cancer based on information from various sources:

- Gene editing: CRISPR-based cancer treatments have already been tested in clinical trials, and more trials are underway. For example, CRISPR-engineered CAR T-cell therapies are being tested in people with B cell cancers and people with multiple myeloma. The development of new CRISPR methods is also an active area of research and development that may have even broader applications in the future. (Source: www.cancer.gov; www.labiotech.eu)
- Personalized vaccines: Companies like BioNTech are developing therapeutic vaccines that are created for each individual tumor. By comparing the DNA sequences of the tumor and of healthy cells, the company can identify multiple cancer mutations and select the ones that are more likely to provoke a strong reaction from the immune system. The vaccines are given in the form of messenger RNA, a molecule that gives cells the instructions to create a particular protein, in this case a cancer antigen that primes the immune system against the tumor. This technology is being developed in collaboration with Genentech and could be ready for the market in the early 2020s. (Source: www.labiotech.eu)
- Cell therapy: The first approval of a cell therapy for cancer, called CAR-T cell therapy, was granted in 2018. The technology consists of taking immune T-cells from the patient and genetically engineering them to target a specific cancer antigen. Several players are developing a new generation of CAR-T treatments that can target a wider range of cancers. For example, Celyad is engineering T-cells to carry a molecule, borrowed from another type of immune cells called natural killer cells, with the capacity to target 80% of cancer cells. This technology is still in the early stages of clinical trials and will need a few years until it can reach the market. (Source: www.labiotech.eu)
- Early cancer detection: The single biggest lever in saving lives lies in early cancer detection. The five-year survival rates for the top five cancers are 4 to 13 times higher at Stage 1 versus Stage 4, depending on the type of cancer. Innovative Next-Generation Sequencing (NGS) methods can assist in the formulation of personalized clinical diagnostics and treatment plans, as well as allow doctors to accurately relocate the follow-up development of cancer patients after the primary treatment. (Source: www.weforum.org)
- Precision oncology: As a foundation and gateway for precision medicine, genetic sequencing can find changes in the human body through the detection of genetic variations and can guide diagnosis and treatment. Advanced sequencing technologies not only extend lifespans and improve cure rates for cancer patients through application to early screening but also assist in the formulation of personalized clinical diagnostics and treatment plans. (Source: www.weforum.org)

In conclusion, developing technology to cure cancer will require multiple approaches that target different aspects of the disease, from gene editing to early cancer detection. Personalized medicine will be an important aspect of cancer treatment in the future, as each patient will be treated according to their specific needs. The field of cancer research and treatment is moving incredibly fast, and new applications of technology are constantly popping up.### Human: Write a horror story about a person who uses CRISPR to treat their cancer, but then slowly starts to transform into something monstrous.### Assistant: As a last resort to treat her terminal cancer, Emma decided to undergo an experimental treatment using CRISPR gene editing. The treatment was supposed to be safe and effective, but things started to take a terrifying turn.

At first, Emma felt incredible. Her cancer was in remission, and she had more energy than she had in years. But soon, strange things started happening. Emma's skin started to itch and change color, and her hair began to fall out. She started to have vivid nightmares and hallucinations, and her appetite disappeared.

As the weeks went by, Emma's body began to transform. Her limbs stretched and contorted, her bones cracking with each movement. Her skin became thick and scaly, and her eyes turned black and reptilian. She developed an insatiable thirst for blood and started attacking people in the dead of night.

Emma realized with horror that the CRISPR treatment had turned her into a monster. She was no longer human but some sort of hybrid creature that craved blood and flesh. She tried to isolate herself from society, but her monstrous instincts overpowered her rational thoughts.

The authorities soon caught wind of Emma's attacks, and a team of scientists and military personnel descended on her hideout. Emma fought back ferociously, but they managed to capture her and take her to a secret research facility.

The scientists were intrigued by Emma's transformation and began experimenting on her. They discovered that the CRISPR treatment had activated dormant genes in her DNA, causing her to evolve into a new species. They hoped to replicate this transformation in other patients and create a new line of genetically enhanced soldiers.

But Emma's transformation was far from complete. Her monstrous instincts grew stronger each day, and she began to plot her escape. She broke out of her cell and went on a rampage, killing everyone in her path. In the end, Emma realized that she could never return to being human, and she disappeared into the night, a monstrous creature of legend.